PT1280526E - Utilizacao de 2-iminobiotin para a producao de um medicamento para prevenir e/ou tratar os recem-nascidos dos efeitos das complicacoes durante o parto - Google Patents
Utilizacao de 2-iminobiotin para a producao de um medicamento para prevenir e/ou tratar os recem-nascidos dos efeitos das complicacoes durante o partoInfo
- Publication number
- PT1280526E PT1280526E PT01964665T PT01964665T PT1280526E PT 1280526 E PT1280526 E PT 1280526E PT 01964665 T PT01964665 T PT 01964665T PT 01964665 T PT01964665 T PT 01964665T PT 1280526 E PT1280526 E PT 1280526E
- Authority
- PT
- Portugal
- Prior art keywords
- effects
- iminobiotin
- production
- prevent
- complications during
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 3
- WWVANQJRLPIHNS-BKPPORCPSA-N 2-iminobiotin Chemical compound N1C(=N)N[C@H]2[C@H](CCCCC(=O)O)SC[C@H]21 WWVANQJRLPIHNS-BKPPORCPSA-N 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 abstract 2
- 102000006538 Nitric Oxide Synthase Type I Human genes 0.000 abstract 2
- 108010008858 Nitric Oxide Synthase Type I Proteins 0.000 abstract 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 abstract 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 abstract 2
- 102000008052 Nitric Oxide Synthase Type III Human genes 0.000 abstract 2
- 108010075520 Nitric Oxide Synthase Type III Proteins 0.000 abstract 2
- 229940124639 Selective inhibitor Drugs 0.000 abstract 2
- 208000033300 perinatal asphyxia Diseases 0.000 abstract 2
- 206010028923 Neonatal asphyxia Diseases 0.000 abstract 1
- 230000035606 childbirth Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201191 | 2000-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1280526E true PT1280526E (pt) | 2005-10-31 |
Family
ID=8171295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01964665T PT1280526E (pt) | 2000-03-31 | 2001-03-30 | Utilizacao de 2-iminobiotin para a producao de um medicamento para prevenir e/ou tratar os recem-nascidos dos efeitos das complicacoes durante o parto |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6894069B2 (pt) |
| EP (1) | EP1280526B1 (pt) |
| AT (1) | ATE296627T1 (pt) |
| AU (1) | AU777022B2 (pt) |
| CA (1) | CA2419302C (pt) |
| DE (1) | DE60111214T2 (pt) |
| DK (1) | DK1280526T3 (pt) |
| ES (1) | ES2243542T3 (pt) |
| NZ (1) | NZ524345A (pt) |
| PT (1) | PT1280526E (pt) |
| WO (1) | WO2001074351A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005531544A (ja) * | 2002-05-06 | 2005-10-20 | ワシントン・ユニバーシティ | Ｅｇｆｒ経路の抑制による緑内障およびｎｏｓ−２発現により媒介される他の状態の治療方法 |
| US20080176907A1 (en) * | 2006-09-19 | 2008-07-24 | Northwestern University | NOS Inhibitors For Treatment Of Motor Deficit Disorders |
| US8932842B2 (en) | 2009-02-11 | 2015-01-13 | Northwestern University | Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition |
| US8278084B2 (en) * | 2009-02-11 | 2012-10-02 | Northwestern University | Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition |
| MX338405B (es) | 2010-05-26 | 2016-04-14 | Neurophyxia B V | Formulaciones de 2-iminobiotina y sus usos. |
| RU2619161C2 (ru) | 2012-06-12 | 2017-05-12 | Альтернативе Гене Экспрессион С.Л. | Элементы рекомбинантной днк для экспрессии рекомбинантных белков в клетке-хозяине |
| FI3389653T3 (fi) | 2015-12-16 | 2023-12-18 | Neurophyxia B V | 2-iminobiotiini käytettäväksi aivosoluvaurion hoidossa |
| CN116230243B (zh) * | 2023-05-04 | 2023-07-21 | 四川大学华西医院 | 难治性癫痫伴高分流量pfo患者的封堵手术诊疗系统 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI9300616A (en) | 1992-11-27 | 1994-06-30 | Wellcome Found | Enzyme inhibitors |
| US5424447A (en) * | 1993-07-07 | 1995-06-13 | The Medical College Of Wisconsin Research Foundation, Inc. | Heme binding compounds and use thereof |
| RU2136661C1 (ru) * | 1993-10-21 | 1999-09-10 | Джи Ди Сирл энд Ко. | Амидинопроизводные, их применение и фармацевтическая композиция |
| DE19711565A1 (de) * | 1997-02-21 | 1998-08-27 | Beiersdorf Ag | Zubereitungen für die Behandlung von Rosacea |
-
2001
- 2001-03-30 DK DK01964665T patent/DK1280526T3/da active
- 2001-03-30 ES ES01964665T patent/ES2243542T3/es not_active Expired - Lifetime
- 2001-03-30 PT PT01964665T patent/PT1280526E/pt unknown
- 2001-03-30 AT AT01964665T patent/ATE296627T1/de active
- 2001-03-30 AU AU87290/01A patent/AU777022B2/en not_active Ceased
- 2001-03-30 EP EP01964665A patent/EP1280526B1/en not_active Expired - Lifetime
- 2001-03-30 US US10/362,051 patent/US6894069B2/en not_active Expired - Lifetime
- 2001-03-30 DE DE60111214T patent/DE60111214T2/de not_active Expired - Lifetime
- 2001-03-30 NZ NZ524345A patent/NZ524345A/en not_active IP Right Cessation
- 2001-03-30 WO PCT/NL2001/000266 patent/WO2001074351A1/en active IP Right Grant
- 2001-03-30 CA CA002419302A patent/CA2419302C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1280526B1 (en) | 2005-06-01 |
| DE60111214D1 (de) | 2005-07-07 |
| AU8729001A (en) | 2001-10-15 |
| CA2419302C (en) | 2009-12-15 |
| ES2243542T3 (es) | 2005-12-01 |
| AU777022B2 (en) | 2004-09-30 |
| US20040002530A1 (en) | 2004-01-01 |
| DE60111214T2 (de) | 2006-03-16 |
| CA2419302A1 (en) | 2001-10-11 |
| EP1280526A1 (en) | 2003-02-05 |
| NZ524345A (en) | 2004-06-25 |
| DK1280526T3 (da) | 2005-09-05 |
| ATE296627T1 (de) | 2005-06-15 |
| US6894069B2 (en) | 2005-05-17 |
| WO2001074351A1 (en) | 2001-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50108153D1 (de) | Vorrichtung zum Beeinflussen von Zellproliferationsmechanismen in Gefässen des menschlichen oder tierischen Körpers | |
| DE3864020D1 (de) | Anordnung zur beseitigung von aktiven mitteln, oertlich verwendet gegen feste tumoren. | |
| CA2328368A1 (en) | Anti-inflammatory agents | |
| ATE324105T1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung von entzündungserkrankungen von kopf und nacken | |
| PT1280526E (pt) | Utilizacao de 2-iminobiotin para a producao de um medicamento para prevenir e/ou tratar os recem-nascidos dos efeitos das complicacoes durante o parto | |
| DK0396184T3 (da) | Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris | |
| WO2003024386A3 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis | |
| WO2003004006A8 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis | |
| NO20030295L (no) | Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser | |
| HK1037980A1 (en) | Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage. | |
| EP1709960A3 (en) | Use of alkanoic acid-containing compositions for straightening hair | |
| NO20012569L (no) | Anvendelse av aryl-substituerte syklobutylalkylaminer for behandling av urininkontinens | |
| MXPA02004699A (es) | Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco. | |
| DE3784738D1 (de) | Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten. | |
| NZ334660A (en) | use of sulodexide to treat diabetic retinopathy | |
| CH412128A (de) | Vorrichtung zur therapeutischen, insbesondere analgetischen Behandlung des menschlichen oder tierischen Körpers | |
| DE3765916D1 (de) | Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde. | |
| AU2001288169A1 (en) | Use of oligomers of hyaluronan for the treatment of an in vitro fertilised embryo and for the denudation of an oocyte before fertilisation | |
| UA38085A (uk) | Спосіб лікування ранніх гестозів | |
| DE50008154D1 (de) | Vorrichtung zum enthäuten von behandlungsgut | |
| ATE291431T1 (de) | Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren | |
| HK1045983A1 (en) | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders. | |
| UA39384A (uk) | Спосіб профілактики жовчнокам'яної хвороби | |
| UA42335A (uk) | Спосіб лікування гнійних ран | |
| RU94020412A (ru) | Способ разворота плода |